Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov site footer revision updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedStudy record page now displays a 403 Forbidden error, replacing the previously visible study details and related content. This blocks access to the trial's core information including objectives, eligibility criteria, and locations.SummaryDifference21%

- Check31 days agoChange DetectedThe revision tag on the page has been updated to v3.7.0, replacing the previous v3.6.6. This denotes a newer documentation version but does not change the study details or data.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling that a new build of the page was released.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page gained an NIH funding note—'2018 ( U.S. NIH Grant/Contract )'—added next to the EudraCT number in the Study Details area, documenting the U.S. funding source for the trial.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a new version of the page. This version update represents an internal update to the page metadata and doesn't change the user-facing content of the study record.SummaryDifference0.0%

Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.